Cargando…

Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma is an aggressive tumor with poor prognosis. Most of the cases are not available for surgery at the stage of the diagnosis and the best clinical practice chemotherapy results in about 12-month median survival. Several tyrosine kinase inhibitors (TKIs) are currently unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poddubskaya, Elena V., Baranova, Madina P., Allina, Daria O., Smirnov, Philipp Y., Albert, Eugene A., Kirilchev, Alexey P., Aleshin, Alexey A., Sekacheva, Marina I., Suntsova, Maria V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127913/ https://www.ncbi.nlm.nih.gov/pubmed/30202637 http://dx.doi.org/10.1186/s40164-018-0113-x

Ejemplares similares

Personalized prescription of imatinib in recurrent granulosa cell tumor of the ovary: case report
por: Poddubskaya, Elena V., et al.
Publicado: (2019)

Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors
por: Poddubskaya, Elena, et al.
Publicado: (2019)

RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer
por: Sorokin, Maxim, et al.
Publicado: (2020)

Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data
por: Sorokin, Maxim, et al.
Publicado: (2022)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020)

Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation
por: Sorokin, Maxim, et al.
Publicado: (2017)

Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability
por: Sorokin, Maksim, et al.
Publicado: (2021)

Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
por: Talreja, Jayant P., et al.
Publicado: (2013)

Multimodality treatment in unresectable cholangiocarcinoma
por: Aghili, Mahdi, et al.
Publicado: (2020)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Biliothorax in a patient with unresectable cholangiocarcinoma
por: Valero, Sara, et al.
Publicado: (2023)

Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
por: Kamashev, Dmitri, et al.
Publicado: (2023)

Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma
por: Sio, Terence T., et al.
Publicado: (2016)

Diagnostic Value of Combinatorial Markers in Colorectal Carcinoma
por: Voronova, Veronika, et al.
Publicado: (2020)

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
por: Gigante, Elia, et al.
Publicado: (2022)

Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data
por: Rabushko, Elizaveta, et al.
Publicado: (2022)

Atlas of RNA sequencing profiles for normal human tissues
por: Suntsova, Maria, et al.
Publicado: (2019)

Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?
por: Pistevou-Gompaki, Kiki, et al.
Publicado: (2008)

Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
por: Jung, Da Hoon, et al.
Publicado: (2014)

Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma
por: Hsiao, Chih-Yang, et al.
Publicado: (2020)

Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma—Role of Interventional Radiology
por: Fabritius, Matthias P., et al.
Publicado: (2021)

Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
por: Zhang, Mengqi, et al.
Publicado: (2023)

Long-term Survival in Hilar Cholangiocarcinoma also Possible in Unresectable Patients
por: Ruys, Anthony T., et al.
Publicado: (2012)

Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
por: Kobayashi, Satoshi, et al.
Publicado: (2018)

Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study
por: Hu, Yubin, et al.
Publicado: (2020)

Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Paz-Fumagalli, Ricardo, et al.
Publicado: (2021)

Liver Transplantation for Unresectable Intrahepatic Cholangiocarcinoma: The Role of Sequencing Genetic Profiling
por: Gruttadauria, Salvatore, et al.
Publicado: (2021)

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib
por: Osuga, Takahiro, et al.
Publicado: (2022)

Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report
por: Melenhorst, Marleen C. A. M., et al.
Publicado: (2015)

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis
por: Al-Adra, D.P., et al.
Publicado: (2015)

Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
por: Seidensticker, Ricarda, et al.
Publicado: (2016)

Case: Authentic multimodal therapy and liver resection for an initially unresectable intrahepatic cholangiocarcinoma
por: Sakata, Koichiro, et al.
Publicado: (2018)

Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Yousaf, Ali, et al.
Publicado: (2019)

Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma
por: Inoue, Tadahisa, et al.
Publicado: (2022)

Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration
por: Song, Jinglin, et al.
Publicado: (2022)

Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review
por: Massani, Marco, et al.
Publicado: (2021)

A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab
por: Saito, Naoto, et al.
Publicado: (2022)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
por: Franssen, Stijn, et al.
Publicado: (2023)

Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
por: Holster, Jessica J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8o4jb6dutnq8br1jh96cljrd0q